Sowell Financial Services LLC Ultragenyx Pharmaceutical Inc. Transaction History

Sowell Financial Services LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$92.19 - $115.71 $67,390 - $84,584	-731 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$106.9 - $167.73 $7,803 - $12,244	-73 Reduced 9.08%	731 $85,000
Q4 2020 Jan 13, 2021	SELL	$84.4 - $177.39 $31,734 - $66,698	-376 Reduced 31.86%	804 $111,000
Q3 2020 Nov 12, 2020	SELL	$72.98 - $90.0 $55,464 - $68,400	-760 Reduced 39.18%	1,180 $97,000
Q2 2020 Aug 13, 2020	BUY	$46.91 - $78.22 $91,005 - $151,746	1,940 New	1,940 $152,000

326

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.37B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.